The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 685K Compounds and 4.6K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

14 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Heteroaromatic compounds as BTK inhibitorsBDB
Boehringer Ingelheim International
Urea and amide derivatives of aminoalkylpiperazines and use thereofBDB
Southern Research Institute
Oxazoline and isoxazoline derivatives as CRAC modulatorsBDB
Lupin
Pyridazine derivatives as RORc modulatorsBDB
Genentech
Substituted phenyl alkanoic acid compounds as GPR120 agonists and uses thereofBDB
Piramal Enterprises
Pyrazines as modulators of GPR6BDB
Takeda Pharmaceutical
Site-activated chelators targeting acetylcholinesterase and monoamine oxidase for Alzheimer's therapy.BDB
The Weizmann Institute of Science
Chalcones: a valid scaffold for monoamine oxidases inhibitors.BDB
Sapienza University of Rome
Carbonic anhydrase inhibitors: synthesis and inhibition studies against mammalian isoforms I-XV with a series of 2-(hydrazinocarbonyl)-3-substituted-phenyl-1H-indole-5-sulfonamides.BDB
Istanbul University
Design and synthesis of 2-amino-pyrazolopyridines as Polo-like kinase 1 inhibitors.BDB
Sunesis Pharmaceuticals
Inhibitors of the tyrosine kinase EphB4. Part 1: Structure-based design and optimization of a series of 2,4-bis-anilinopyrimidines.BDB
Astrazeneca
A novel series of potent and selective ketone histone deacetylase inhibitors with antitumor activity in vivo.BDB
Irbm/Merck Research Laboratories